Cargando…
5-Methoxytryptophan alleviates atrial structural remodeling in ibrutinib-associated atrial fibrillation
BACKGROUND: Ibrutinib is an effective and well-tolerated treatment for B-cell lymphomas but is associated with an increased risk of atrial fibrillation (AF) by altering the structure of the atrium. 5-Methoxytryptophan (5-MTP) inhibits inflammatory and fibrotic processes. This study aimed to determin...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558721/ https://www.ncbi.nlm.nih.gov/pubmed/37810107 http://dx.doi.org/10.1016/j.heliyon.2023.e19501 |